Immunetics, Inc.

Immunetics, Inc. specializes in in vitro diagnostic (IVD) kits used for detecting antibodies linked to specific infectious diseases. Their primary focus is on tests for Borrelia burgdorferi (the bacterium responsible for Lyme disease) and Bacillus anthracis (the cause of anthrax). These include enzyme immunoassay (EIA) kits for screening IgG and IgM antibodies, as well as Western blot kits for confirming Lyme disease diagnoses. These products are designed exclusively for laboratory use to assist in diagnosing infections.

Immunetics, Inc. is based in the United States. Their diagnostic devices are intended for use in the U.S. market, where they are regulated by the FDA. The company’s products are tailored for laboratory settings to support clinical decision-making in infectious disease testing, particularly for Lyme disease and anthrax.

Immunetics, Inc.’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. These registries are used to track and authorize Class II medical devices in the U.S., ensuring compliance with regulatory requirements before they enter the market.

Immunetics, Inc.’s diagnostic devices fall under the FDA’s Class II classification. This classification applies to devices that generally pose moderate risk and require special controls to ensure their safety and effectiveness. Class II devices, like those from Immunetics, are subject to 510(k) premarket notifications to demonstrate substantial equivalence to a legally marketed predicate device before authorization.

The diagnostic kits from Immunetics, Inc. are designed to detect specific antibodies in patient samples, aiding in the diagnosis of infectious diseases like Lyme disease and anthrax. For example, their EIA kits screen for IgG and IgM antibodies to Borrelia burgdorferi, while their Western blot kits provide confirmatory testing for Lyme disease. These tests help laboratories identify infections by confirming the presence of disease-specific markers in a patient’s blood or other biological samples.